Progression of Cognitive and Physical Symptoms in Multiple Sclerosis

Multiple Sclerosis Clinical Trial

Official title:

Progression of Cognitive, Affective, and Physical Symptoms in Multiple Sclerosis.

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00922831
• Other study ID #: 080514
• Status: Withdrawn
• First received: June 16, 2009
• Last updated: April 10, 2018
• Start date: August 2008
• Est. completion date: August 2013

Study information

• Verified date: April 2018
• Source: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to look at multiple sclerosis patients process of awareness, learning, and judging status over a 3 year time period.

Description:

Patients with multiple sclerosis (MS) frequently experience cognitive and emotional difficulties. Theses neuropsychiatric symptoms are known to be associated with reduced quality of life. However, little is known about the evolution of MS patients' neuropsychiatric difficulties and how these neuropsychiatric changes may be related to other MS symptoms. The purpose of the present study is to examine MS patients' cognitive and emotional status over time as part of standard neuropsychological evaluations in a private practice setting. MS patients presenting for neuropsychological evaluation at the MidAmerica Neuroscience Institute will be provided with the option of participating in thorough evaluation of their cognitive and affective MS symptoms. They will then be followed clinically and receive re-evaluation over a period of 3 years on a yearly basis. It is hoped that this study will help us obtain a better understanding of the factors associated with worsening cognition in MS. A greater understanding of the factors associated with cognitive and affective decline in MS help could lead to the early identification and treatment of at-risk patients.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 2013
• Est. primary completion date: August 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male/female subjects at least 18 years of age with a diagnosis of Clinically Definite Multiple Sclerosis (CDMS) or Clinically Isolated Syndrome (CIS)as confirmed by a neurologist.

• Subjects must be able to give written informed consent and comply with the study protocol. Subjects must also be able to read, write and understand English.

• Are capable of performing the requirements of the neuropsychological test battery.

Exclusion Criteria:

• As judged by the investigator, any clinically significant, unstable or major concomitant disorder or medications.

• In the opinion of the Investigator should not participate in the study.

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute	University of Missouri, Kansas City